Call for papers - Precision Oncology
We are pleased to announce a new cross-journal thematic series on ‘Precision Oncology’ across a number of BMC journals within the oncology portfolio to help bring together the latest research on precision oncology.
The thematic series is now open for submission of original research and review articles - for further information about this series please click here.
Featured image of the month
Pathological findings of CCSST with EWSR1 and CREM rearrangements. a Metastatic CCSST of the lymph nodes (100×). b Tumor cells were polyhedral to spindle-shaped and had oval to round nuclei with pale to clear and eosinophilic cytoplasm (400×). c FISH of EWSR1 split signals. Tumor cells showed EWSR1 split signal with a pair of fused (arrow) and split (arrow head) patterns (1000×). d FISH of CREM split signals. Tumor cells showed CREM split signal with a pair of fused (arrow) and split (arrow head) patterns (1000×).
Aims and scope
Diagnostic Pathology is an open access, peer-reviewed, online journal that considers research in surgical and clinical pathology, immunology, and biology, with a special focus on cutting-edge approaches in diagnostic pathology and tissue-based therapy.
The journal covers all aspects of surgical pathology, including classic diagnostic pathology, prognosis-related diagnosis (tumor stages, prognosis markers, such as MIB-percentage, hormone receptors, etc.), and therapy-related findings. The journal also focuses on the technological aspects of pathology, including molecular biology techniques, morphometry aspects (stereology, DNA analysis, syntactic structure analysis), communication aspects (telecommunication, virtual microscopy, virtual pathology institutions, etc.), and electronic education and quality assurance (for example interactive publication, on-line references with automated updating, etc.).
Dr Anil Parwani, Editor-in-Chief
"Diagnostic Pathology has emerged as a premier journal that aims to publish cutting edge articles focused on diagnostic pathology with an emphasis on novel morphological and molecular findings that make an impact on diagnosis of neoplastic and non-neoplastic diseases. The goal of the editorial board and our team is to highlight the cross-roads of diagnostic pathology and new tools and technologies that are exciting, challenging and making an impact on the practice of pathology. We will continue to bring updates in the field of diagnostic pathology by way of novel and interesting case reports, research and original articles and a series of key review articles by experts in the field that will emphasize the new developments which are disease-specific and highlight contemporary and novel technologies that are changing the practice of diagnostic pathology. This is an exciting time in pathology as we are confronted with a new frontier of science and technology which continues to evolve and accelerate the discipline of diagnostic pathology and we wish to take our readers with us on this exciting journey. We want to collaborate with our reviewers and our readers to make Diagnostic Pathology a premier and trusted source of new and exciting developments in the field of diagnostic pathology."
Dr Anil Parwani, Ohio State University
2017 Journal Metrics
64 days to first decision for reviewed manuscripts only
54 days to first decision for all manuscripts
126 days from submission to acceptance
17 days from acceptance to publication
157 Altmetric Mentions